Vical Incorporated (NASDAQ:VICL) shares crossed above its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of $0.00 and traded as high as $0.84. Vical shares last traded at $0.81, with a volume of 725,083 shares.
Several brokerages have recently issued reports on VICL. Zacks Investment Research raised Vical from a “hold” rating to a “buy” rating and set a $0.75 price objective on the stock in a report on Friday, July 19th. ValuEngine raised Vical from a “hold” rating to a “buy” rating in a report on Thursday, August 1st.
The firm has a market capitalization of $18.54 million, a PE ratio of -1.07 and a beta of 0.31. The company has a fifty day moving average price of $0.77 and a 200-day moving average price of $1.00.
Vical Company Profile (NASDAQ:VICL)
Vical Incorporated researches and develops biopharmaceutical products based on its DNA delivery technologies for the prevention and treatment of serious or life-threatening diseases. The company was founded in 1987 and is headquartered in San Diego, California.
Recommended Story: How do candlesticks reflect price movement?
Receive News & Ratings for Vical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vical and related companies with MarketBeat.com's FREE daily email newsletter.